Found "Public health policy": 1,044 results
Sort by
Z - A

E^2U Research Unit under HITAP Develops Health Policy Options Based on ‘Environment-Economy’ Relationship

The world is rapidly changing. In mid-2023, NASA found that the average temperature in the Northern Hemisphere was the highest in 170 years, with ice melting 6-7 times faster compared to 25 years ago. Antonio Guterres, the Secretary-General of the United Nations (UN), announced

Exploring Vaccine Implementation for Gavi Graduating Countries: Bhutan’s Rotavirus Vaccine Economic Evaluation

Post-graduation from Gavi support in 2016, the Bhutan Health Trust Fund took up investment for vaccine provision in the country according to its mandate. The Fund also aims to “eliminate financing uncertainties for priority core components of the Primary Health Care Services out of the income genera

Exploring HTA Development in Tanzania: A Scoping Visit

On April 7-10, 2015, a HITAP team visited Dar es Salaam, Tanzania, for a country scoping visit to explore the potential areas for introducing health technology assessment (HTA) to support health resource allocation, focusing on the investment or disinvestment of health technologies. This visit was c

Expert in estimating quality of life values, student in using them in economic evaluations: My experience participating in an HTA workshop at JIPMER, India

My first trip to India was to participate in a workshop on health technology assessment (HTA) organized by the Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER) and the Health Intervention and Technology Assessment Program (HITAP) in Puducherry, India on 3-5 October 2019.

Experience in Using HTA for Expanding UHC Benefit Package to Cover Rare Diseases and High-Cost Drugs among Seven Middle and High-Income Countries: A targeted literature review

This policy brief provides a summary of a recent review of the definition of rare diseases, high cost and how HTA has been used in the case of rare diseases in seven countries. The countries were purposively selected based on them having established HTA policies and availability of resources in the

Expanding access to high-cost medicines under the Universal Health Coverage scheme in Thailand: review of current practices and recommendations

There is a growing demand for public health insurance programmes to reimburse high-cost medicines, including those that do not represent good value-for-money. This demand is likely to inhibit financial sustainability, given the growth of new technologies and public demands for expanded access to car
10 / Page